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Abstract
Macrophage cells that are stimulated by two different ligands that bind to G-protein-coupled receptors (GPCRs) usually
respond as if the stimulus effects are additive, but for a minority of ligand combinations the response is synergistic. The G-
protein-coupled receptor system integrates signaling cues from the environment to actuate cell morphology, gene
expression, ion homeostasis, and other physiological states. We analyze the effects of the two signaling molecules
complement factors 5a (C5a) and uridine diphosphate (UDP) on the intracellular second messenger calcium to elucidate the
principles that govern the processing of multiple signals by GPCRs. We have developed a formal hypothesis, in the form of a
kinetic model, for the mechanism of action of this GPCR signal transduction system using data obtained from RAW264.7
macrophage cells. Bayesian statistical methods are employed to represent uncertainty in both data and model parameters
and formally tie the model to experimental data. When the model is also used as a tool in the design of experiments, it
predicts a synergistic region in the calcium peak height dose response that results when cells are simultaneously stimulated
by C5a and UDP. An analysis of the model reveals a potential mechanism for crosstalk between the Gai-coupled C5a
receptor and the Gaq-coupled UDP receptor signaling systems that results in synergistic calcium release.
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Introduction
The G-protein-coupled signal transduction system integrates a
wide range of intercellular signals and actuates downstream
pathways. G-protein-coupled receptors (GPCRs) are composed of
seven a-helices that span the plasma membrane, an extracellular
domain that is activated by an agonist and an intracellular domain
that binds a guanine nucleotide heterotrimer made up of different
a, b, and c subunit isoforms. This receptor system accounts for
40–50% of modern medicinal drug targets but only 10% of the
known receptors are targeted by drugs [1]. Though the system is
physiologically and pharmacologically important, the mechanism
by which the system integrates multiple signals is not well
understood [2].
We address the G-protein-mediated route to calcium release in
RAW264.7 cells. When activated by a specific ligand, the G
protein heterotrimer dissociates to free Ga-GTP and Gbc. Specific
Ga and Gbc isoforms are able to bind specific isoforms of
phospholipase C b (PLCb) and catalyze the synthesis of inositol
(1,4,5)-triphosphate (IP3) and diacylglycerol (DAG) from phos-
phatidylinositol (4,5)-bisphosphate (PIP2) [3,4]. In addition to its
catalytic activity, PLCb acts as a GTPase for Ga-GTP [5]. IP3
binds to specific receptor-channels on the membrane of the ER to
release Ca
2+ into the cytosol [6]. DAG and Ca
2+ bind to and
activate protein kinase C (PKC) which may phosphorylate and
inactivate specific PLCb isoforms [7]. G protein receptor kinase
(GRK) is activated once it is phosphorylated by PKC [8] and is
localized to the plasma membrane by Gbc [9]. Though
phosphorylation has not been shown to be necessary for GRK
activation, we have assumed so in our model because phosphor-
ylation by PKC may release the inhibition of GRK2 by being
bound to calmodulin [8]. Activated GRK can then phosphorylate
specific GPCRs which leads to receptor inactivation—perhaps
directly or by arrestin activity [8]. In this complex signal
transduction network, Ga and Gbc subunits have different
patterns of specificity for PLCb isoforms and calcium is an
important cofactor in several important feedback loops [10].
The two extracellular signaling ligands we consider here are
C5a and UDP. The small peptide C5a is a potent anaphylotoxin
and a strong chemoattractant for many immune system compo-
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predominantly coupled through Gai-linked heterotrimers. Mac-
rophage cells and their precursors, monocytes, express several
receptors that are specific to extracellular nucleotides and it has
been shown that the P2Y6 receptor, which is sensitive to UDP,
regulates the production and secretion of the chemokine
interleukin 8 (IL-8) in monocytes [12]. The UDP response is
mediated by Gaq-linked heterotrimers, but other receptors in the
P2Y family may respond to UDP and couple the signal through
other G protein isoforms [13].
Four recent models have sought to explore various aspects of the
G protein coupled signal transduction system in detail. Lukas et al.
compare measured calcium response over a range of bradykinin
doses to their model predictions [14]. Mishra and Bhalla built a
model to investigate the role of IP4 as a signal coincidence detector
in the GPCR pathway [15]. The model by Lemon et al. predicts
the calcium response to UTP stimulation and is the closest in focus
to our model [16]. A recent model of calcium dynamics in RAW
cells has been proposed that is quite similar to this model, but does
not deal with crosstalk between receptors or formal statistical
uncertainty in model predictions [17,18].
Several hypotheses for the mechanism of crosstalk and synergy
among GPCR-mediated pathways have been proposed. Crosstalk
among GPCR-mediated pathways is important both physiologically
and pharmaceutically. Quitterer et al. propose that crosstalk is
mediated by Gbc exchange between Gai-coupled and Gaq-coupled
receptors [19]. Zhu et al. speculated that PLC is under either
conditional or dual regulation of Gbc and Ga [20]. Though these
hypothetical mechanisms for crosstalk among G protein coupled
receptor systems are conceptually plausible we have not found these
or any other of the many competing hypothetical mechanisms tested
in the context of a quantitative mathematical model [2].
In this paper Bayesian statistical inference is used to provide a
rigorous connection between the mathematical model derived
from mass-action kinetics, prior information from in-vitro
biochemical studies and heterogeneous experimental data. The
prior distribution over the parameters represents our uncertainty
before observing a set of experimental data. A broad, high
variance, prior distribution means we are quite uncertain and a
concentrated, low variance, prior means we are more certain
about the parameter a priori. The objective of our inference is the
posterior distribution over the parameters because it is an
informed estimate of both the value of the parameter and the
uncertainty in the parameter value. The posterior distribution over
the parameters is then used as a tool for experiment design to
estimate the model-based posterior distribution over observable
quantities such as the cytosolic calcium concentration and to drive
the design of new experiments. This statistical approach is possible
in a model of this size because of the abundance and quality of the
data collected for this study.
Results
There are two main features of the structure of our model,
shown in Figure 1, which contribute to crosstalk in the system and
produce the key dynamical features in the calcium response:
isoform specificity and calcium-dependent feedback. As we will
show, by including multiple isoforms of PLCb and Ga as well as
the negative feedback mediated by PKC, GRK and the IP3
receptor itself, we are able to predict the synergistic interaction
between C5a and UDP observed in the experimental data.
Our representation of the G-protein-coupled signal transduc-
tion system includes C5a and P2Y6 receptors, Gai2, Gaq, Gbc,
PLCb3, PLCb4, PIP2, DAG, IP3, PKC, GRK2, calcium buffer, a
Na
2+/Ca
2+ exchanger, a sarco(endo)plasmic reticulum Ca
2+-
ATPase (SERCA) pump, IP3 receptors and RGS. The model is
composed of 53 coupled ordinary differential equations with 84
parameters and 24 non-zero initial conditions. The complete
model equations are shown in Figure S7 and a more detailed
model diagram is shown in Figure S6. The parameters and initial
conditions are in Table S2 and Table S1, respectively. Where
available, we have relied on in-vitro or in-vivo biochemical
experiments for the reactions and parameter values (see Support-
ing Information). In cases where the biochemical parameter values
were not known, we chose physically reasonable values. Twenty of
the 84 parameters most relevant to the knock-down and wild-type
data were estimated from cytosolic calcium measurements as
described in the Methods section. Most reactions were assumed to
be governed by mass-action kinetics, but for a few proteins—such
as RGS—the mechanism of regulation is not known in enough
detail and we have approximated with Michaelis-Menten kinetics
or a phenomenological function.
We briefly discuss the reactions involving the Na
2+/Ca
2+
exchanger, SERCA pump, IP3 receptors, RGS and calcium buffer
because they are important for the faithful representation of the
system in our model. Regulators of G protein signaling (RGS) are
GTPase proteins that down-regulate the extent of signaling [21];
RGS2 at least is expressed in RAW264.7 macrophage cells and
therefore an RGS activity is included in our model. The mechanism
of activation of RGS2 as it relates to Gaia n dG aq signaling is not
entirely known and is difficult to assess because antibodies that
specifically recognize RGS2 are not widely available [22–24]. We
have assumed constitutive activity and expect as more information
becomes available a more accurate model of the regulation of RGS2
andotherRGSisoformswillbepossible.TheSERCApumphelpsto
bring the cytosolic Ca
2+ concentration back to the resting level after
stimulation. We have modeled the SERCA pump as in the Keizer
and DeYoung model [25]. The IP3 dependent opening of ER
calciumchannelswas found to becooperative [26]andwe haveused
Author Summary
The G protein signal transduction system transmits a wide
variety of extracellular signals including light, odors, and
hormones, to intracellular effectors in diverse cell types in
eukaryotes. G-protein-coupled receptors are involved in
many diseases including inflammation, cardiac dysfunc-
tion, and diabetes, and are the targets of 40–50% of
modern drugs. Despite the physiological and pharmaco-
logical importance of this signal transduction system it is
not known how the system buffers and integrates
information at a biochemical level. The multiple receptors
expressed by every cell pass their signals through a
common set of downstream effectors distinguished by
multiple isoforms with slightly different specificities and
activities. The coupling among these pathways causes
interactions among the signals sent by the different classes
of receptors. We have developed a mechanistic model of
the G protein signal transduction system from the receptor
to the central intracellular second-messenger calcium. We
have used statistical methods to integrate a diverse set of
experimental data into our model and quantify confidence
in our model predictions. We used this model, trained on
single receptor data, to predict the signal processing of
two G-protein-coupled-receptor signals. Validation exper-
iments support our hypothesized mechanism for dual
receptor signal processing and the predictions of the
model.
Dual Receptor GPCR Crosstalk Model
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coefficient of four [25,27]. Finally, many other proteins such as
calmodulin and the fluorescent indicator Fura-2 bind Ca
2+.B e c a u s e
our measurements reflect these effects, we have included a general
buffer for cytosolic calcium.
Isoform Specificity
Complement factor 5a activates the C5a receptor which is a
Gai-coupled receptor [28]. The released Gbc dimer activates
PLCb2 and PLCb3 which are lumped and called PLCb3 in our
model because: (i) the activity of Gbc-activated PLCb3 has been
shown to be greater than Gbc-activated PLCb2i nin-vitro studies
and (ii) Gaq activates both PLCb2 and PLCb3 so the structural
connections from Gbc and Gaq to PLCb2 and PLCb3 in the
model are identical [4,29]. PLCb1 is activated by Gbc and Gaq,
but RAW264.7 macrophage cells do not express this isoform, so
we have not included it in the model. PLCb3 then catalyzes the
hydrolysis of phosphatidylinositol (4,5)-bisphosphate (PIP2) into
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).
UDP stimulates the P2Y6 receptor and the associated Gaq-
GTP activates both PLCb3 [30] and PLCb4 [31]. The GTPase
rate of Gaq is increased 1000-fold when bound to PLCb [5]. Due
to this rapid hydrolysis rate, we have assumed, in our model, that
PLCb3 or PLCb4 bound Gaq-GTP may only hydrolyze one
molecule of PIP2 before releasing Gaq-GDP. Additionally, the
Gbc released by the P2Y6 receptor also activates PLCb3 [30], but
does not activate PLCb4 [32].
Our model assumes that PLCb3 does not simultaneously bind
Gbc and Gaq. Indeed, a biochemical study of PLCb2 activity in
reconstituted membrane fractions strongly argues that Gaq and
Gbc do not simultaneously bind this effector [33]. While this was
specifically demonstrated for PLCb2, we implicitly assume the
same holds for PLCb3 because we lump the two in our model.
This is a mechanistic assumption of our model and an interesting
issue for future testing with directed experiments.
Calcium-Dependent Feedback
Though important for response specificity, the dynamical
control of calcium release is not limited to the forward pathway
in this system. Calcium participates in feedback processes that
both enhance and inhibit its own release at multiple points in the
pathway. There are four main nodes of calcium-dependent
feedback control in our model: PLCb, IP3 receptor, protein
kinase C (PKC) and G protein receptor kinase (GRK).
Calcium enhances its own release by binding to the EF-hand
domain on PLCb and is required for PLCb to hydrolyze PIP2 into
IP3 and DAG [34]. Because the dissociation constant for PLCb-
Ca
2+ in our model is larger than the basal concentration of
cytosolic calcium, as more Ca
2+ is released from the ER, more
PLCb-Ca
2+ becomes available to bind Gaqo rG bc. This positive
feedback mechanism accelerates the release of Ca
2+.
In our model, Ca
2+ and IP3 cooperatively open the channel
between the ER and the cytosol. It is believed that Ca
2+ initially
stimulates the IP3 receptor with maximal stimulatory effect at
100–300 nM [6]. At higher concentrations, Ca
2+ has an inhibitory
effect. We use the IP3 receptor model structure in the Keizer and
DeYoung model for this component [25].
Protein kinase C (PKC) has been shown to phosphorylate PLCb3
which inhibits PLCb3 activation due to Gaqa n dG bc [35,36]. PKC
is activated when bound to DAG and Ca
2+ [7,37]. Because the
preferred order of binding is not entirely known, PKC, DAG and
Ca
2+ form a thermodynamic cycle of reversible reaction with only
the PKC-DAG-Ca
2+ form active. In our model, the dissociation
constant of PKC and Ca
2+ is much greater than the basal Ca
2+
concentration,andupon binding DAG,the PKC-DAGcomplexhas
a higher affinity for Ca
2+ making the order of binding preferentially
PKC to DAG then PKC-DAG to Ca
2+. It is not known whether
PLCb4 is also regulated by PKC. We have assumed, in our model,
the same mechanism of PKC regulation of PLCb3 and PLCb4.
The final key calcium-dependent feedback loop in our model is
mediated by G protein receptor kinase (GRK). GRK2 phosphor-
ylates and inactivates ligand-bound C5a receptors when activated
by PKC and Gbc. In sequence, PKC phosphorylates GRK2
which causes translocation to the plasma membrane [8]. When
properly localized, GRK2 may bind Gbc and then phosphorylate
the C5a-C5a receptor complex to inactivate it [38]. This simplified
representation of the receptor desensitization mechanism does not
include arrestin activity, multiple receptor phosphorylation sites
and other fine grain or slower biochemical interactions that may
be present in-vivo.
Single Ligand Experiments
Having specified the structure of our model, we direct our
attention to the parameters. We estimate 20 of the 84 parameters
in our model using a dataset composed of 96 Fura-2 time series
measurements as described in the Materials and Methods section.
Each experiment consists of 3–4 samples from different wells in a
96 well plate. There are 15 experiments spanning 9 doses of C5a
Figure 1. The model for crosstalk between the Gai and Gaq pathways depends on both differential specificity and activity for Gai,
Gaq, and Gbc interactions with PLCb3 and PLCb4 to catalyze PIP2 hydrolysis and calcium-dependent feedback control mediated by
GRK and PKC. Selected model parameters are informed by calcium measurements taken for various ligand doses on wild-type and cell lines with
shRNAi knockdowns on the proteins shown in red.
doi:10.1371/journal.pcbi.1000185.g001
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in the dataset (see Figure S3). The dataset also contains calcium
measurements on 5 different shRNAi knockdown cell lines
constructed by lentiviral infection (see Figure S4). The time
interval between samples is approximately 3–4 seconds and each
time series is approximately 100–300 seconds of post-stimulation
data. Table 1 shows a summary of the knockdown data used for
statistical parameter estimation for this model in addition to the
wild-type experiments.
We find that our model is generally quantitatively consistent
with the experimental data within measurement uncertainty.
Where the model is less consistent with the data – specifically for
the GRK knockdown experiment – we find the deviation has a
reasonable biological explanation. The summary of the dataset
and the fit of the model to each single ligand experiment are
available in the Supporting Information. We briefly discuss some
issues relating to goodness of fit and the Bayesian parameter
estimation here.
While most optimization procedures produce a point estimate of
the parameters that maximize the goodness of fit of the model to
the observed data, the Bayesian procedure we have employed here
estimates the entire posterior distribution of the parameters given
the data. This information is valuable for qualitatively and
quantitatively evaluating the precision of the parameters estimates.
Figure 2 shows, as a qualitative evaluation, that while the a-priori
forward and reverse binding rates for the receptors (C5aR and
P2YR) are uncorrelated they are correlated in the posterior
distribution. The calcium measurements have informed and
constrained the posterior estimates of the dissociation constants
to be approximately 5 nM and 250 nM for the C5aR and P2YR
respectively. We have quantitatively computed marginal highest
posterior density (HPD) confidence intervals for each of the twenty
parameters we have estimated from the data. Those estimates are
shown in Table S3. Those parameters with large HPD intervals
are not well informed by the measurements and are candidates for
directed biochemical experiments.
Wild-Type Experiments
The calcium responseto C5a adaptsand returns tothe basal level,
but the UDP response has a sustained elevated calcium level that
slowly decays. Figure 3 shows two representative experiments of the
response of the wild-type cell to stimulation with C5a and UDP. We
expect that the fit to this data will be good because 20 key model
parameterswerefitusinganexperimentaldatasetthatincludedthese
experiments – the fit is indeed accurate. The point estimate curve is
constructed from the maximum a-posteriori parameters from an
MCMC chain. The prediction intervals are estimated by Monte
Carlo sampling from the posterior parameter distribution and the
measurement error distribution conditional on the parameters. The
prediction confidence intervals generally cover the observed data.
Knockdown Experiments
Lentiviral infection is used to introduce small hairpin RNAs to
interfere with the translation of the key signaling proteins GRK2,
Gai2, Gaq, PLCb3 and PLCb4 [39]. There are three main
sources of uncertainty in the knockdown experiment model
predictions: parametric uncertainty, measurement uncertainty
and knockdown efficiency uncertainty. We have dealt with the
first two sources in the previous section on wild-type experiments.
Here we address prediction variability due to knockdown
efficiency uncertainty by using nominal parameter values.
Figure 4 shows simulations and experimental data for three
representative knockdown experiments. The upper-left panel of
Figure 4 shows a GRK knockdown line stimulated with 250 nM
C5a. Because GRK2 desensitizes the C5a receptor, we expect that
by eliminating the feedback mechanism, the calcium peak will be
higher and more sustained. The experimental data as well as the
model indeed show that effect. Quantitatively, the model
prediction shows a greater effect than the experimental data. A
likely reason is that the model only considers one isoform of GRK
while there are four isoforms expressed in the RAW264.7 cell line
(GRK1,2,4,6). If more than one isoform can desensitize the C5a
receptor, the effective knockdown in desensitization function will
be less than as measured by western blot analysis on GRK2.
While GRK does not desensitize the P2Y receptor in our model,
it is a buffer for Gbc released from Gaq. Reducing the amount of
GRK will shift the equilibrium towards more Gbc bound to
PLCb3 and thus more calcium release even though GRK does not
directly feed back on the P2Y6 receptor. The top-right panel in
Figure 4 shows that, based on the model, the peak intracellular
calcium concentration is expected to be very slightly higher in the
GRK2 knockdown line when stimulated by 25 mM UDP. A
comparison of the experimental peak heights of the wild-type and
GRK knockdown cell line data by t-test cannot reject the null
Table 1. Dataset used for parameter estimation.
Cell Line Measured Fraction Knockdown Model Value Sample Size
C5a UDP
qRT-PCR Western Nominal Lower Upper ,10 nM 10–100 nM .100 nM ,1 mM 1–10 mM .10 mM
Wild-type – – – – – 4 8 3 5 5 4
GRK2 (2) 90%67%, n=5 40%66%, n=6 40.0% 22.0% 58.0% 2 12 2 3 1 5
Gai2 (3) 83%65%, n=4 73%66%, n=5 73.0% 55.0% 91.0% – 5 – 5 – 7
Gaq (3) 70%68%, n=7 66%623%, n=2 66.0% 0.0% 95.0% – 3 – 1 – 3
PLCb3( 1 ) – 8 3 % 615%, n=3 83.0% 38.0% 100.0% – 3 – – – 3
PLCb4 (1) 87%66%, n=5 – 87.0% 69.0% 100.0% – 4 – 4 – 4
Five different cell lines that have a perturbation in the level of a key signal transduction protein were constructed by shRNAi lentiviral infection. The calcium response
from these cell lines in addition to the wild-type cell line were used to fit relevant parameters in the model. Because shRNAi does not entirely remove the protein
product, the fraction knockdown was estimated by qRT-PCR and by Western blot analysis. The standard error (se) was computed for each estimate and the upper and
lower confidence intervals were computed as 63?se. The knockdown confidence intervals are used in the GPCR model to construct prediction confidence intervals for
the calcium response. Where several cell lines were constructed for each knockdown, the best was selected and reported in parenthesis. The sample size for each
knockdown-ligand dose combination is shown in the last 6 columns.
doi:10.1371/journal.pcbi.1000185.t001
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of the GRK knockdown is expected to be so slight that the effect
size is overwhelmed by the measurement error in the data. The
effect of the uncertainty in the GRK2 knockdown fraction impacts
the range of the confidence intervals of the predicted C5a response
much more than the confidence intervals of the predicted UDP
response which is consistent with GRK2 being a more significant
component of the C5a response.
Our model structure has PLCb3 stimulated by either Gbc or
Gaq. Because the C5a response signals only through PLCb3 the
effect of the knockdown is expected to be more pronounced for the
C5a response than for the UDP response. The bottom-left panel of
Figure 4 confirms that the model prediction is consistent with the
representative experiment. The UDP response activates PLCb3
through Gbc, but also activates PLCb3 and PLCb4 with Gaq.
Therefore, we expect that the calcium response should be more
robust to perturbations in just one of the PLCb isoforms. The
UDP response in the PLCb3 knockdown line (bottom right panel
of Figure 4) shows that our model predicts the knockdown effect to
be small relative to the total magnitude of the response in part due
Figure 2. This figure shows that the single and pairwise marginal posterior distributions for the ligand binding reactions for the
P2YR and C5aR receptors. The vertical line in the single marginal posterior distributions shows the point estimate that were selected. The
posterior distributions show the dissociation constants for the reactions are tightly constrained by the data, while the values of the forward and
reverse rates that make up the ratio are not as well constrained by the data. Additionally, as expected the UDP binding rates are not correlated with
the C5a binding rates. Marginal posterior distributions for all parameters and a discussion of the point estimate selection can be found in Figure S2.
doi:10.1371/journal.pcbi.1000185.g002
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response.
Because this dataset was used for parameter estimation, the fit of
model to the data may overstate the accuracy of the model.
Nonetheless, the good fit does suggest that the model warrants
being tested in truly predictive experiments; we describe such
experiments in the following section.
Double Ligand Experiments
We examine our model response to a simultaneous stimulation by
C5a and UDP because it has been shown experimentally that
macrophage cells respond synergistically to such conditions [40]. To
quantify the amount of synergy or non-additivity that is present in
the calcium response, a synergy ratio is computed for each ligand dose
pair. The numerator of the ratio is the peak offset from baseline of
the intracellular calcium concentration. The denominator of the
ratio is the sum of the peak offsets when the cell or model is
stimulated with only one ligand. A synergy is present when the ratio
is greater than one implying the peak height is greater than expected
from an additive combination of ligand effects. While this is certainly
not the only possible measure of synergy it is widely adopted and has
been used in previous studies on calcium synergy [40].
The leftpanel ofFigure5 shows theresults of model simulationsat
nominal parameters for a grid of doses of C5a and UDP. In the dose
response surface, there is a ridge of synergistic calcium release for a
moderate dose of UDP. We tested the model prediction with the
experiment design measuring the synergy ratio at the points denoted
as black open circles in the left panel of Figure 5. A x
2 goodness-of fit
test comparing the model expected synergy ratio to the observed
synergy ratio fails to reject the null hypothesis that the data were
generated by the model mechanism (p-value<1.0). The root-mean-
squared error (RMSE) deviation between the predicted and actual
experimental data is 0.492. By way of comparison, the RMSE
between the data and the null model of no synergy is 1.044. We
therefore conclude that the model predictions are consistent with the
experimental observations. It should be noted that measurements of
synergy in RAW cells are noisy and the ridge occurs at low doses of
UDP. Notwithstanding, the phenomenon has been reported [40]
and has been observed by us in this cell line.
The right panel of Figure 5 shows the same synergy dose
response surface but for a GRK knockdown cell line. The synergy
ridge observed in the wild-type cell simulation is changed in the
GRK knockdown simulation indicating the C5a receptor
desensitization mechanism mediated by GRK is important for
the synergistic release of calcium. In the next section we pursue
this conclusion in more detail, developing a conceptual explana-
tion of the mechanism of crosstalk and synergy within our model.
Discussion
G-protein-coupled receptors form a complex network of
interacting proteins that generally exhibits the properties of a
system in which each receptor signal is buffered from the others.
For a minority of ligand combinations, however, crosstalk between
pairs of receptors is apparent. Due to the complexity and
importance of the system many hypothetical mechanisms have
been proposed to explain the crosstalk [2]. In particular,
simultaneous Gbc and Gaq binding to PLCb [20] and Gbc
exchange between Gai and Gaq-coupled receptors have been
proposed as potential mechanisms [19]. While our model does not
eliminate these potential mechanisms, we do show that the
mechanism represented in our model is consistent with a full range
of experimental data including a variety of doses of C5a and UDP,
C5a and UDP stimulation of five different knockdown cell-lines
and double-ligand dose response experiments.
To our knowledge, this is the first multireceptor GPCR model
and the first to address the complex phenomenon of crosstalk
between GPCR receptor pathways that has been statistically
estimated and validated with experimental data. This important
phenomenon plays a role in processes as diverse as chemotaxis and
perhaps drug interactions. In our model, the primary mechanism
of synergy is due to the cooperative opening of the IP3 receptor.
The robustness of the synergy is due to the feedback of GRK on
the C5a receptor and the specificity of the synergy is due to the
interaction patterns between specific Ga isoforms and PLCb
isoforms. The simultaneous binding model [20] accounts for the
specificity of synergy, but not the robustness pattern of the synergy.
We observe in the model that if the Gaq-PLCb3-Ca
2+ and
Gaq-PLCb4-Ca
2+ binding reactions are inhibited, the system still
exhibits synergy. We conclude from this observation that the
crosstalk mechanism is mediated by Gbc. If the binding reaction
of Gbc to phosphorylated GRK2 is removed, the synergy is
eliminated. Furthermore, if the GRK2-mediated phosphorylation
of complexed C5a receptors is removed, the double ligand
response is additive. We deduce then that the synergy mechanism
Figure 3. Model simulations are compared to experimental data. The point estimate is computed using the posterior distribution of the
parameter as estimated by Markov chain Monte Carlo given the data from 96 experiments on C5a and UDP at various doses in combination with 5
different shRNAi knockdown cell lines. The 95% posterior predictive intervals are estimated by Monte Carlo simulations including both parameter and
measurement uncertainty. The measured mean and approximate 95% confidence intervals of four replicates is shown by a black dot and error bar. (A)
C5a at 250 nM was introduced at 20s and the experimentally observed pulse in cytosolic calcium concentration is shown. (B) The qualitative shape of
the calcium pulse for 25 mM UDP is different than for 250 nM C5a. The pulse does not completely adapt and return to the prestimulated level. For
both ligands, the model prediction confidence intervals overlap the data error bars that indicate the model fit is consistent with the data within the
measurement uncertainty.
doi:10.1371/journal.pcbi.1000185.g003
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However, GRK2 phosphorylation does not entirely explain the
synergy mechanism.
In our model, the calcium released from the IP3 receptor is a
function of the number of receptor molecules complexed to IP3
raised to the fourth power [41]. Therefore, for a small range of IP3
concentration, the amount of Ca
2+ released is more than additive
(see Figure S8). We conclude from our analysis of the model that
the synergy ridge in Figure 5 arises because the GRK2 mediated
mechanism holds the IP3 concentration in this non-additive region
for most concentrations of C5a. The UDP response does not have
the GRK2 mediated feedback and thus only shows a synergistic
response for a small range of UDP concentration. If the GRK2
desensitization is removed from the model, the synergy ridge is
removed and synergy is only present at low doses of C5a and UDP
(see Figure 5).
The Bayesian method we have used for this model has several
advantages for the estimation of model parameters in complex
mechanistic system models. We have used an informative prior to
exclude negative rate constants from the permitted parameter space.
We have also used the prior distribution to center our a priori
expectations of the rate constant at values obtained from in-vitro and
otherbiochemicalexperiments.TheBayesianupdateruleallowedus
toestimateparameterswith our best current dataset andthen update
thoseestimatesasnewdatabecameavailablefromthecalciumassay.
In this way, we were able to iteratively refine and recalibrate our
model with the most recent data available during data collection
period for this project. The posterior distribution provides not only
an estimate of the rate constants, but the entire distribution, from
which we can calculate highest posterior confidence intervals and
posterior correlations between parameters. For example, the
posterior correlation between the binding and unbinding rates for
the UDP-P2Y receptor complex were highly correlated, but those
two constants were uncorrelated with the corresponding rates for the
C5a-C5a receptor complex reaction even though we imposed no
correlations a priori. Finally, the algorithmic methods for collecting
Figure 4. The model simulation results for GRK and PLCb3 knockdown cell lines stimulated with C5a and UDP are shown. The
experimental mean61 s.d. of 3–4 replicates within one experimental run is shown in black. The knockdown simulation result with nominal
knockdown fraction and parameters is shown in red and the wild-type simulation result is shown in green for comparison. Upper and lower model
99% confidence intervals (shown as blue dashed lines) are simulated using the upper and lower knockdown fraction values from Table 1. As expected
the Ca
2+ response to C5a in the GRK knockdown line (A) was increased compared to wild-type. The quantitative deviation between the model and
data is possibly due to the availability of multiple redundant GRK isoforms. (B) The expected effect of the GRK knockdown on the UDP response is an
increase in the cytosolic calcium levels. Because GRK2 does not directly desensitize the P2Y receptor in this model, the effect is likely due to a
reduction of sequestration of Gbc by GRK. (C) The signal transduction of the C5a response is predominantly through the PLCb3 isoform. The effect of
the PLCb3 knockdown is much greater for C5a than for UDP (D).
doi:10.1371/journal.pcbi.1000185.g004
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considerably in recent years in terms of speed and robustness
We have shown that the signal transduction system as it is
represented by our model does not require simultaneous binding
of Gaq and Gbc to PLCb3 to cause a synergistic Ca
2+ response
due to simultaneous stimulation by C5a and UDP. We have
shown that our representative model is consistent with this
experimental dataset in RAW264.7 macrophage cells, but we
have not excluded all other potential mechanisms that may be
absent or regulated differently in this cell line compared to other
macrophage cell lines. Indeed there are a few examples of
statistical discrepancies between the model and experiments in our
dataset (Table S4). These differences are substrate for further
experimentation and modeling. The purpose of our model is to
provide a quantitative tool to aid in reasoning about such complex
interacting systems so that meaningful experiments can be
designed to explore and understand the biological mechanism.
Materials and Methods
The model equations are given in Figure S7. The initial
conditions and parameter values are in Table S1 and Table S2,
respectively. All the data used in this work and a stand-alone
implementation of the model is provided at http://genomics.lbl.
gov/supplemental/flaherty-gpcr/. The model was simulated using
CVODE [42] and the GNU Scientific Library. Further details on
materials and methods are available in Dataset S1.
Experimental Methods
Intracellular free calcium in cultured adherent RAW264.7 cells
was measured in a 96-well plate format using the Ca
2+-sensitive
fluorescent dye Fura-2 [43,44]. A Molecular Devices FLEXstation
scanning fluorometer was used to measure fluorescence using a
bottom read of a 96-well plate. Each well was sampled
approximately every 4 seconds. The measurement protocol is
described in AfCS experimental protocol ID #PP00000211
(available from http://www.signaling-gateway.org). The parame-
ters in ligand concentration model were estimated using FITC
solution in the FLEXstation scanning fluorometer as described in
Molecular Devices Maxline Application Note #45 and in Protocol
S1 (see also Figure S5).
Statistical Inference
Twenty of the 84 parameters were chosen to be estimated from
data based on relevance to the experimental hypothesis. Only
those parameters that related to the knockdown experiments in the
dataset were estimated and are denoted with a star in Table S2.
We used data to estimate only the two forward rate constants in
the enzymatic mass-action equations because the forward and
reverse rate constants for a given reaction will be highly correlated
in the posterior distribution making estimation by Markov chain
methods computationally expensive. An analysis of the sensitivity
of the model to each parameter is shown in Figure S9.
For each estimated parameter we constructed an independent
Gaussian prior on a log scale with a mean chosen based on relevant
literature and a standard deviation of 0.25. We found that this prior
variance was sufficiently permissive to allow exploration of the space
while still constraining the rates to be physically reasonable. The
prior distribution over the parameters allows the incorporation of
both soft and hard constraints in the parameter estimates. Parameter
sets with zero measure are not permitted in the posterior distribution
and parameter sets with small measure must be assigned a large
likelihood in order to have a large posterior probability.
The likelihood is a function of the parameters (h) and links the
prior distribution with the posterior distribution under Bayes rule
Pr h y j ðÞ ~
pyh j ðÞ Pr h ðÞ
Pr y ðÞ
where y denotes the observed data.
In our model, the likelihood function is a Gaussian distribution
according to the non-linear regression equation y=f(h)+e,
Figure 5. The model is used as a predictive tool to infer the effect of stimulating the cell simultaneously with UDP and C5a that
signal through the Gaq and Gai pathways, respectively. Synergy was measured as the ratio of peak height offset from baseline attained from
simultaneous stimulation to the peak height offset calculated by the sum of the responses to each ligand individually. (A) Expected synergy ratio as a
function of UDP and C5a dose (truncated at 1.5). The simulations show a ridge of synergy at a moderate UDP dose for most C5a doses. The black
circles indicate dose combinations points of experiments that were conducted to test the model. (B) Expected synergy ratio as a function of UDP and
C5a dose for a simulated GRK2 knockdown cell line. Without the GRK-mediated negative feedback to keep the IP3 generation from the C5a receptor
within the non-linear range of calcium release the ridge in the synergy dose response is diminished. The synergy in the GRK knockdown simulation is
not entirely eliminated because the shRNAi knockdown of GRK does not constitute a complete loss-of-function and low concentrations of ligand are
still able to synergize. Furthermore, the asymmetric synergy dose response surface is more symmetric in the GRK knockdown simulation because the
asymmetric calcium-dependent feedback mechanism is reduced.
doi:10.1371/journal.pcbi.1000185.g005
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2), where f(h) is the deterministic model prediction. The
posterior distribution is of interest because it informs us as to the
most probable setting of the parameters as well as the uncertainty
in the values.
The Metropolis-Hastings algorithm [45] was used to estimate
the posterior density of the parameters Pr(h|y). Three independent
chains were simulated from different initial parameter values (see
Figure S1). To assess convergence of the posterior distribution
estimate, we used the Gelman-Rubin potential scale reduction
factor (PSRF) [46]. The multivariate PSRF is 2.44 and 95% of the
individual PSRFs were less than 1.5. A PSRF value of one
indicates that the distribution has converged and values near one
are close to converged.
Posterior prediction confidence intervals were constructed using
the percentiles from the predictive distribution approximated with
2000 Monte Carlo samples from Pr(ynew|hi) at each of 100 simple
random samples from Pr(h|y) obtained from
Pr ynew y j ðÞ ~
ð
Pr ynew h j ðÞ Pr h y j ðÞ dh&
X 100
i~1
Pr ynew hi j ðÞ Pr hi y j ðÞ ,
where Pr(ynew|hi),N(f(h),s
2) and s
2 is the pooled variance estimate,
which is computed as an average of the variances of all the time
points in each of the 29 wild-type experiments. These average
variances were weighted by the number of technical replicates in
each experiment and then averaged to yield the estimate s
2.A
small factor of 1 nM
2 was added to each variance estimate to
bound variance estimates away from zero.
Supporting Information
Dataset S1
Found at: doi:10.1371/journal.pcbi.1000185.s001 (0.11 MB
DOC)
Figure S1 This figure shows exemplar MCMC realizations for
parameter k109f (the UDP+P2YR forward binding rate) from
three independent chains. The chains have converged to the
stationary distribution which is the posterior distribution as
measured by the PSRF (see Materials and Methods).
Found at: doi:10.1371/journal.pcbi.1000185.s002 (0.20 MB
DOC)
Figure S2 Posterior distributions and correlations The first
figure shows that the pairwise marginal posterior distributions for
the ligand binding reactions for P2YR and C5aR. The posterior
distributions show the dissociation constants for the reactions are
tightly constrained by the data, while the values of the forward and
reverse rates that make up the ratio are not as well constrained by
the data. Additionally, the UDP binding rates are not correlated
with the C5a binding rates. k108f and k108r are the P2YR
forward and reverse rates and k101f and k101r are the C5aR rates.
The next two figures show the one-way marginal posterior density
estimates from three independent MCMC chains with approxi-
mately 30,000 samples. The 20 estimates parameters are along the
rows and the independent chains are along the columns. In each
plot, the light blue density is the prior density and the green,
purple and orange densities are the posterior densities. The
vertical line shows the parameter value used in the model
simulations in the paper and listed in Table S3. All of the densities
are plotted on a log scale. Each marginal posterior distribution
estimate is constructed from independent MCMC chains. The
results from each chain (three of them) are shown in the columns
of the second figure below. In some cases the algorithm sampled
heavily from one mode that was not explored as heavily by
another chain. However, the PSRF criterion used to assay
convergence and a visual inspection of overall posterior density
correspondence do indicate that the posterior distributions are
sufficiently sampled by all three chains in aggregate. Furthermore,
the fit of the model to the data as shown in Figure S3 shows that
the model point estimates are effective in fitting the actual calcium
measurements.
Found at: doi:10.1371/journal.pcbi.1000185.s003 (0.55 MB
DOC)
Figure S3 Peak height dose response. This figure shows the
single ligand calcium dose responses for C5a and UDP
stimulation.
Found at: doi:10.1371/journal.pcbi.1000185.s004 (0.21 MB
DOC)
Figure S4 Knockdown simulations. This figure shows represen-
tative simulations and data for each knockdown experiment. A
complete set of all 96 experiments is provided in a supplementary
folder.
Found at: doi:10.1371/journal.pcbi.1000185.s005 (0.69 MB
DOC)
Figure S5 Input model fit. This figure shows the input model
(described in Materials and Methods) fit to the FITC measure-
ments. The ligand concentration that the cell sees does not transit
instantaneously from 0 to the final concentration. The ligand
concentration is expected to take an amount of time that is
significant on the scale of the measurements made for this study to
reach the final concentration.
Found at: doi:10.1371/journal.pcbi.1000185.s006 (0.12 MB
DOC)
Figure S6 Large pathway diagram.
Found at: doi:10.1371/journal.pcbi.1000185.s007 (0.18 MB
DOC)
Figure S7 System of differential equations. This figure shows the
complete set of differential equations used to simulate the model.
These equations are also available in the source c code for the
model supplied. This system of equations with the initial
conditions and nominal parameter values reported in Table S1
and Table S2, respectively, completely define the model and allow
for the reproduction of the simulations used in this paper on any
platform.
Found at: doi:10.1371/journal.pcbi.1000185.s008 (1.62 MB
DOC)
Figure S8 Hill function self-synergy. Consider a Hill function,
Hx ðÞ ~
xn
xnzKn. y1~
x1
K
is a dimensionless critical concentration
y*, below which self-synergy will occur. Based on the analysis, we
conclude that: (i) n must be greater than 1 for self-synergy to occur,
(ii) self synergy never occurs if the concentration x exceeds
equilibrium constant K (y.1), and (iii) for n.2, there is a large
range of concentration for self-synergy. In the G protein model, x,
is the concentration of IP3-IP3R, H(x) is the rate of change in
cytosolic calcium concentration and n=4. We have tested the
validity of this self synergy hypothesis by stimulating the cells with
both 20 nM UDP and 40 nM UDP (data not shown). Though at
such low ligand concentrations, the measurement variability is
high, we observed that the synergy ratio, on average was 1.17
compared to a value of 1.25 predicted by the model.
Found at: doi:10.1371/journal.pcbi.1000185.s009 (0.02 MB
DOC)
Figure S9 Parameter sensitivity analysis. The parameter of
interest is varied by 10% while all other parameters are kept
Dual Receptor GPCR Crosstalk Model
PLoS Computational Biology | www.ploscompbiol.org 9 September 2008 | Volume 4 | Issue 9 | e1000185constant. The parameters are grouped according to their
functionalities. The sensitivity coefficient is the ratio of the relative
change in the peak height to the relative change in the parameter
value. The four most sensitive parameters (sensitivity coefficient .2)
in the Cacyt category are Vqssk50 (IP3+IP3K_a-.IP4+IP3K_a
(Vmax)), Kqssk50 (IP3+IP3K_a-.IP4+IP3K_a (Km)), a1 (Ca leak
into the cell from outside), and Kex (Na/Ca exchange activation
const). The top 3 most sensitive parameters in the PLCb3 category
are: k21bf* (PLCb3_Ca_Gbg_PIP2-.PLCb3_Ca_Gbg+IP3+
DAG), k20f (Gbg+PLCb3_Ca-.PLCb3_Ca_Gbg),k21af* (PLCb3_
Ca_Gbg+PIP2-.PLCb3_Ca_Gbg_PIP2). A star next to the para-
meter name indicates it was estimated.
Found at: doi:10.1371/journal.pcbi.1000185.s010 (0.04 MB
DOC)
Protocol S1 FITC protocol.
Found at: doi:10.1371/journal.pcbi.1000185.s011 (0.03 MB
DOC)
Table S1 Model initial conditions. This table shows the initial
conditions used for the model. The model was run for sufficient
time for the species states in the model to reach equilibrium before
ligand stimulation was added. The number of molecules was
calculated using a cell volume of 1 pL.
Found at: doi:10.1371/journal.pcbi.1000185.s012 (0.05 MB
DOC)
Table S2 Model parameters. This table shows the nominal
parameters used for the model. Parameter distributions that were
estimated are shown as shaded rows and with a star next to the
parameter name in the table. The prior distribution for each
parameter is as described in the Materials and Methods section
with mean value specified by the column labeled ‘‘prior’’.
Found at: doi:10.1371/journal.pcbi.1000185.s013 (0.14 MB
DOC)
Table S3 Parameter posterior uncertainty and references. This
table shows the HPD intervals as computed by the R CODA
library function ‘‘hpdinterval’’. HPD intervals for each of the three
MCMC chains were calculated and the union of those intervals is
reported for each parameter in this table. The prior value reported
in Table S2 was set using information from references listed in the
appropriate column. The references used to form the basis of the
parameter estimates are shown in the last column.
Found at: doi:10.1371/journal.pcbi.1000185.s014 (0.37 MB
DOC)
Table S4 Goodness of fit evaluation. We use the mean squared
error criterion to evaluate the goodness of our model fit to the
data. We have used this data in the estimation procedure and thus
does not constitute a true validation. However, we show that in
general our model fits the bulk of the data. Those areas of lack-of-
fit are usually due to extraordinary experiment-to-experiment
variation and in some cases point to unaccounted mechanisms.
We elaborate on one such mechanism (multiple GRK isoforms) in
the text of the article.
Found at: doi:10.1371/journal.pcbi.1000185.s015 (0.27 MB
DOC)
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